Cargando…

The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate

BACKGROUND: D-myo-inositol-1,2,6-triphosphate (α-trinositol, AT) is a polyanionic molecule capable of chelating divalent metal ions with anti-tumour and anti-cachectic activity in a murine model. METHODS: To investigate the role of zinc in this process, mice bearing cachexia-inducing MAC16 tumour we...

Descripción completa

Detalles Bibliográficos
Autores principales: Russell, S T, Siren, P M A, Siren, M J, Tisdale, M J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833253/
https://www.ncbi.nlm.nih.gov/pubmed/20145616
http://dx.doi.org/10.1038/sj.bjc.6605562
_version_ 1782178373930319872
author Russell, S T
Siren, P M A
Siren, M J
Tisdale, M J
author_facet Russell, S T
Siren, P M A
Siren, M J
Tisdale, M J
author_sort Russell, S T
collection PubMed
description BACKGROUND: D-myo-inositol-1,2,6-triphosphate (α-trinositol, AT) is a polyanionic molecule capable of chelating divalent metal ions with anti-tumour and anti-cachectic activity in a murine model. METHODS: To investigate the role of zinc in this process, mice bearing cachexia-inducing MAC16 tumour were treated with AT, with or without concomitant administration of ZnSO(4). RESULTS: At a dose of 40 mg kg(−1), AT effectively attenuated both weight loss and growth of the MAC16 tumour, and both effects were attenuated by co-administration of Zn(2+). The concentration of zinc in gastrocnemius muscle increased with increasing weight loss, whereas administration of AT decreased the levels of zinc in plasma, skeletal muscle and tumour, which were restored back to control values after administration of ZnSO(4). CONCLUSION: These results suggest that zinc is important in both tumour growth and cachexia in this animal model.
format Text
id pubmed-2833253
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-28332532011-03-02 The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate Russell, S T Siren, P M A Siren, M J Tisdale, M J Br J Cancer Translational Therapeutics BACKGROUND: D-myo-inositol-1,2,6-triphosphate (α-trinositol, AT) is a polyanionic molecule capable of chelating divalent metal ions with anti-tumour and anti-cachectic activity in a murine model. METHODS: To investigate the role of zinc in this process, mice bearing cachexia-inducing MAC16 tumour were treated with AT, with or without concomitant administration of ZnSO(4). RESULTS: At a dose of 40 mg kg(−1), AT effectively attenuated both weight loss and growth of the MAC16 tumour, and both effects were attenuated by co-administration of Zn(2+). The concentration of zinc in gastrocnemius muscle increased with increasing weight loss, whereas administration of AT decreased the levels of zinc in plasma, skeletal muscle and tumour, which were restored back to control values after administration of ZnSO(4). CONCLUSION: These results suggest that zinc is important in both tumour growth and cachexia in this animal model. Nature Publishing Group 2010-03-02 2010-02-09 /pmc/articles/PMC2833253/ /pubmed/20145616 http://dx.doi.org/10.1038/sj.bjc.6605562 Text en Copyright © 2010 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Translational Therapeutics
Russell, S T
Siren, P M A
Siren, M J
Tisdale, M J
The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate
title The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate
title_full The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate
title_fullStr The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate
title_full_unstemmed The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate
title_short The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate
title_sort role of zinc in the anti-tumour and anti-cachectic activity of d-myo-inositol 1,2,6-triphosphate
topic Translational Therapeutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833253/
https://www.ncbi.nlm.nih.gov/pubmed/20145616
http://dx.doi.org/10.1038/sj.bjc.6605562
work_keys_str_mv AT russellst theroleofzincintheantitumourandanticachecticactivityofdmyoinositol126triphosphate
AT sirenpma theroleofzincintheantitumourandanticachecticactivityofdmyoinositol126triphosphate
AT sirenmj theroleofzincintheantitumourandanticachecticactivityofdmyoinositol126triphosphate
AT tisdalemj theroleofzincintheantitumourandanticachecticactivityofdmyoinositol126triphosphate
AT russellst roleofzincintheantitumourandanticachecticactivityofdmyoinositol126triphosphate
AT sirenpma roleofzincintheantitumourandanticachecticactivityofdmyoinositol126triphosphate
AT sirenmj roleofzincintheantitumourandanticachecticactivityofdmyoinositol126triphosphate
AT tisdalemj roleofzincintheantitumourandanticachecticactivityofdmyoinositol126triphosphate